Logo image of KME.MI

KME GROUP SPA (KME.MI) Stock Fundamental Analysis

BIT:KME - Euronext Milan - IT0004552359 - Common Stock - Currency: EUR

0.88  -0.03 (-3.51%)

Fundamental Rating

1

KME gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 39 industry peers in the Metals & Mining industry. KME may be in some trouble as it scores bad on both profitability and health. KME has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KME had negative earnings in the past year.
KME had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: KME reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: KME reported negative operating cash flow in multiple years.
KME.MI Yearly Net Income VS EBIT VS OCF VS FCFKME.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M 200M

1.2 Ratios

The Return On Assets of KME (-4.45%) is worse than 79.49% of its industry peers.
The Return On Equity of KME (-34.68%) is worse than 89.74% of its industry peers.
Industry RankSector Rank
ROA -4.45%
ROE -34.68%
ROIC N/A
ROA(3y)3.02%
ROA(5y)1.79%
ROE(3y)1.63%
ROE(5y)0.95%
ROIC(3y)N/A
ROIC(5y)N/A
KME.MI Yearly ROA, ROE, ROICKME.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

KME's Operating Margin has declined in the last couple of years.
KME has a Gross Margin of 30.17%. This is comparable to the rest of the industry: KME outperforms 58.97% of its industry peers.
KME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.17%
OM growth 3Y-61.86%
OM growth 5Y-50.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KME.MI Yearly Profit, Operating, Gross MarginsKME.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2K 4K 6K

More info and screens

1

2. Health

2.1 Basic Checks

KME does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KME has less shares outstanding
Compared to 5 years ago, KME has less shares outstanding
Compared to 1 year ago, KME has a worse debt to assets ratio.
KME.MI Yearly Shares OutstandingKME.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
KME.MI Yearly Total Debt VS Total AssetsKME.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 0.75, we must say that KME is in the distress zone and has some risk of bankruptcy.
KME has a Altman-Z score of 0.75. This is amonst the worse of the industry: KME underperforms 89.74% of its industry peers.
KME has a debt to FCF ratio of 9.84. This is a negative value and a sign of low solvency as KME would need 9.84 years to pay back of all of its debts.
The Debt to FCF ratio of KME (9.84) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.25 is on the high side and indicates that KME has dependencies on debt financing.
KME has a Debt to Equity ratio of 1.25. This is amonst the worse of the industry: KME underperforms 82.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF 9.84
Altman-Z 0.75
ROIC/WACCN/A
WACC8.88%
KME.MI Yearly LT Debt VS Equity VS FCFKME.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

KME has a Current Ratio of 0.72. This is a bad value and indicates that KME is not financially healthy enough and could expect problems in meeting its short term obligations.
KME has a Current ratio of 0.72. This is amonst the worse of the industry: KME underperforms 89.74% of its industry peers.
A Quick Ratio of 0.30 indicates that KME may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.30, KME is doing worse than 89.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.3
KME.MI Yearly Current Assets VS Current LiabilitesKME.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for KME have decreased strongly by -642.68% in the last year.
The Revenue for KME has decreased by -26.34% in the past year. This is quite bad
The Revenue has been growing by 120.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-642.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-328.98%
Revenue 1Y (TTM)-26.34%
Revenue growth 3Y424.94%
Revenue growth 5Y120.96%
Sales Q2Q%-26.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KME.MI Yearly Revenue VS EstimatesKME.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

KME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KME.MI Price Earnings VS Forward Price EarningsKME.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

KME's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. KME is more expensive than 74.36% of the companies in the same industry.
KME's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KME is cheaper than 97.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.24
EV/EBITDA 18.52
KME.MI Per share dataKME.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KME GROUP SPA

BIT:KME (4/15/2025, 7:00:00 PM)

0.88

-0.03 (-3.51%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap250.31M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-14.86%
DP-0.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF 4.24
P/OCF 2.79
P/B 0.99
P/tB N/A
EV/EBITDA 18.52
EPS(TTM)-0.97
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY23.6%
OCF(TTM)0.32
OCFY35.88%
SpS5.6
BVpS0.89
TBVpS-0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.45%
ROE -34.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.17%
FCFM 3.71%
ROA(3y)3.02%
ROA(5y)1.79%
ROE(3y)1.63%
ROE(5y)0.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-61.86%
OM growth 5Y-50.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.25
Debt/FCF 9.84
Debt/EBITDA 8.21
Cap/Depr 53.79%
Cap/Sales 1.93%
Interest Coverage N/A
Cash Conversion 233.01%
Profit Quality N/A
Current Ratio 0.72
Quick Ratio 0.3
Altman-Z 0.75
F-Score5
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)49.67%
Cap/Depr(5y)76.47%
Cap/Sales(3y)14.27%
Cap/Sales(5y)10.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-642.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-328.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.34%
Revenue growth 3Y424.94%
Revenue growth 5Y120.96%
Sales Q2Q%-26.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-126.42%
EBIT growth 3Y100.22%
EBIT growth 5Y10.24%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.04%
FCF growth 3YN/A
FCF growth 5Y18.49%
OCF growth 1Y-43.3%
OCF growth 3YN/A
OCF growth 5Y27.95%